Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.08% Nasdaq Down 0.83%
Streaming
Ticker Tape: On

ArQule Inc. (ARQL)

-NasdaqGM
1.68 Down 0.07(4.00%) 4:00PM EDT
|After Hours : 1.68 0.00 (0.00%) 4:00PM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Prev Close:1.75
Open:1.75
Bid:1.67 x 10300
Ask:1.68 x 2900
1y Target Est:3.56
Beta:1.23
Earnings Date:May 5 - May 9 (Est.)
Day's Range:1.66 - 1.76
52wk Range:1.62 - 3.10
Volume:180,670
Avg Vol (3m):326,286
Market Cap:105.61M
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARQLDown 4.00%105.61M
ARRYUp 0.53%476.73M
ASTX 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.49
Quarterly EPS Est (Mar-14) :-0.11
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-0.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ArQule, Inc., a clinical-stage biotechnology company, researches and develops cancer therapeutics. Its lead product candidate tivantinib is an inhibitor of the c-Met receptor tyrosine kinase and its biological pathway, which is in Phase 3 clinical... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback